project id: TCGA-MESO; case submitter id: TCGA-YS-AA4M; concentration: 0.16; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.81; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.73; rna integrity number: 9.1; age at index: 66; days to birth: -24176; days to death: 84; ethnicity: not reported; gender: male; race: white; vital status: Dead; year of birth: 1947; year of death: 2013; age at diagnosis: 24176; ajcc pathologic m: M1; ajcc pathologic n: N0; ajcc pathologic stage: Stage IV; ajcc pathologic t: T1b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C45.0; last known disease status: not reported; morphology: 9050/3; primary diagnosis: Mesothelioma, malignant; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Pleura, NOS; synchronous malignancy: No; tissue or organ of origin: Pleura, NOS; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 91; days to sample procurement: 0; initial weight: 30.0; portion submitter id: TCGA-YS-AA4M-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 85.0;